TMRFFSOMERSET MINERALS LTD.

About SOMERSET MINERALS LTD. (TMRFF)

SOMERSET MINERALS LTD. (TMRFF) is a Other Industrial Metals & Mining company headquartered in Perth, WA, Australia whose shares trade over-the-counter on the Pink tier.

Silexion Therapeutics Corp, a biopharmaceutical company, discovers and develops RNA interference (RNAi)-based cancer drugs and delivery systems to treat malignant solid tumors. The company engages in the treatment of solid tumors through its proprietary LODER delivery platform. Its products comprise SiG12D-LODER that has completed pre-clinical studies and an open label Phase I clinical trial for the treatment of pancreatic cancer; Prostate-LODER, which is in pre-clinical studies for the treatment of prostate cancer; and GBM-LODER that is in pre-clinical studies to target Glioblastoma Multiform, a malignant primary brain tumor.

Products and services

Junior Exploration Company

TMRFF key facts

Ticker symbol

TMRFF

Market tier

Pink

Sector

Basic Materials

Industry

Other Industrial Metals & Mining

Headquarters

Perth, WA, Australia

Country of incorporation

AU

Year of incorporation

2018

Employees

7

Estimated market cap

$682.5K (as of May 14, 2025)

Shares outstanding

524,969,426

Reporting standard

International Reporting: ASX - Australian Securities Exchange

Audit status

Audited

Fiscal year end

6/30

Latest filing

Interim Financial Report (Sep 30, 2022)

SOMERSET MINERALS LTD. leadership

• Jason Cornelius Bahnsen — President
• Melanie Jane Ross — Company Secretary

Explore more: Other Industrial Metals & Mining stocks · Basic Materials sector · Pink stocks · OTC stocks starting with T